FDA Authorizes Marketing of First Home Flu and COVID-19 Combination Test Outside of Emergency Use Authorities Post author:PacConAdmin Post published:October 7, 2024 Post category:Uncategorized FDA granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test Source: FDA Press Releases Tags: aaps Read more articles Previous PostFDA Roundup: October 4, 2024 Next PostWCG Releases 2024 Report on Top Issues Impacting Clinical Research Sites You Might Also Like Medical Devices Need Top Priority in Supply Chain, Conference Speakers Say March 18, 2024 FDA Shares Case Study of Using AI/ML to Identify Patients for COVID-19 Drug August 12, 2024 New FDA AI Tool Identifies AE Changes in Drug Labeling August 6, 2024